Virtus ETF Advisers’s Olema Pharmaceuticals OLMA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-10,579
| Closed | -$61.7K | – | 541 |
|
|
2024
Q4 | $61.7K | Buy |
10,579
+3,185
| +43% | +$18.6K | 0.03% | 442 |
|
|
2024
Q3 | $88.3K | Buy |
7,394
+129
| +2% | +$1.54K | 0.04% | 393 |
|
|
2024
Q2 | $78.6K | Buy |
7,265
+235
| +3% | +$2.54K | 0.04% | 410 |
|
|
2024
Q1 | $79.6K | Sell |
7,030
-485
| -6% | -$5.49K | 0.04% | 394 |
|
|
2023
Q4 | $105K | Buy |
+7,515
| New | +$105K | 0.07% | 337 |
|
|
2022
Q2 | – | Sell |
-17,135
| Closed | -$73K | – | 462 |
|
|
2022
Q1 | $73K | Sell |
17,135
-1,015
| -6% | -$4.32K | 0.03% | 346 |
|
|
2021
Q4 | $170K | Buy |
18,150
+11,036
| +155% | +$103K | 0.06% | 285 |
|
|
2021
Q3 | $196K | Sell |
7,114
-365
| -5% | -$10.1K | 0.09% | 276 |
|
|
2021
Q2 | $209K | Buy |
+7,479
| New | +$209K | 0.09% | 316 |
|